Small Intestine Cancer Research
Targeted Treatment for Rare Digestive Tract Cancers May Extend SurvivalPosted: December 7, 2018
In an early-phase trial, dabrafenib plus trametinib shrank tumors in patients with biliary tract cancer and adenocarcinoma of the small intestine whose tumors had a specific mutation in the BRAF gene.
Drug Combination Shrinks Duodenal Polyps in People with Familial Adenomatous PolyposisPosted: April 7, 2016
In a small clinical trial of people with an inherited condition that greatly increases gastrointestinal cancer risk, a two-drug combination shrank precancerous lesions in the duodenum.